Affective Symptoms in Early-Onset Dementia

Neurologic Clinics

Volumn 29, Issue 1, 2011, Pages 99-114

  Podell, Kenneth ^a,b   Torres, Karen ^c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CAMBRIDGE HEALTH ALLIANCE   (United States)

Author keywords

Alzheimer disease; Anxiety; Chronic traumatic encephalopathy; Depression; Early onset dementia; Neuropsychological deficits

Indexed keywords

ALENDRONIC ACID; CITALOPRAM; ZOLPIDEM; ZOLPIDEM TARTRATE;

ADL DISABILITY; ALZHEIMER DISEASE; AMNESIA; ANXIETY; ANXIETY DISORDER; APPETITE; AUTOIMMUNE THYROIDITIS; BRAIN DYSFUNCTION; DEGENERATIVE DISEASE; DELUSION; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE MARKER; DISORIENTATION; EARLY ONSET DEMENTIA; ELECTROENCEPHALOGRAM; EMOTIONAL DISORDER; FLUENCY DISORDER; FRONTOTEMPORAL DEMENTIA; GENERALIZED ANXIETY DISORDER; HALLUCINATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; MAJOR DEPRESSION; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SHORT TERM MEMORY; SLEEP DISORDER; SPEECH DISORDER; STRESS; TELEMETRY; TRAUMATIC BRAIN INJURY;

BRAIN; DEMENTIA; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIDDLE AGED; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; RISK FACTORS;

EID: 78650233220     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2010.10.009     Document Type: Review

References (57)

1. Langenecker S.C., Lee H.J., Bieliauskas L.A. Neuropsychology of depression and related mood disorders. Neuropsychological assessment of neuropsychiatric and neuromedical disorders 2009, 523-559. Oxford University Press, United Kingdom. I. Grant, K. Adams (Eds.).
2. Biessels G.J., Staekenborg S., Brunner E., et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
3. Solomon A., Kivipelto M., Wolozin B., et al. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 2009, 28:75-80.
4. Qui C., Winblad B., Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005, 4:487-499.
5. Nalivaevaa N.N., Fisk L., Kochkina E.G., et al. Effect of hypoxia/ischemia and hypoxic reconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann N Y Acad Sci 2004, 1035:21-33.
6. Sierksma A.S., Van den Hove D.L., Steinbusch W.M., et al. Major depression, cognitive dysfunction and Alzheimer's disease: is there a link?. Eur J Pharmacol 2010, 626:72-82.
7. Dong H., Yuede C.M., Yoo H.S., et al. Corticosterone and related receptor expression are associated with increased β-amyloid plaques in isolated Tg2576 mice. Neuroscience 2008, 155:154-163.
8. Jeong Y.H., Park C.H., Yoo J., et al. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APP V7171-CT100 transgenic mice, and Alzheimer's disease model. FASEB J 2006, 20:729-731.
9. Rothman S.M., Mattson M.P. Adverse stress, hippocampal networks, and Alzheimer's disease. Neuromolecular Med 2010, 12:56-70.
10. Csermansky J.G., Dong H., Fagan A.M., et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry 2006, 163:2164-2169.
11. Sousa N., Lukoyanov N.V., Madeira M.D., et al. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 2000, 97:253-266.
12. Coffey C.E., Wilkinson W.E., Weiner R.D., et al. Quantitative cerebral atrophy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993, 50:7-16.
13. MacQueen G., Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research. Mol Psychiatry 2010, [Epub ahead of print].
14. Ownby R.L., Crocco E., Acevedo A., et al. Depression and risk for Alzheimer's disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006, 63:530-538.
15. Green R.C., Cupples L.A., Kurz A., et al. Depression as a risk factor for Alzheimer disease: the MIRAGE study. Arch Neurol 2003, 60:753-759.
16. Geerlings M.I., den Heijer T., Koudstaal P.J., et al. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer's disease. Neurology 2008, 70:1258-1264.
17. McKinnon M.C., Yucel K., Nazarov A. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009, 34:41-54.
18. Myint A.M., Kim Y.K., Verkerk R., et al. Kynurenine pathway in major depression; evidence of impaired neuroprotection. J Affect Disord 2007, 98:143-151.
19. Vythilingam M., Vermetten E., Anderson G.M., et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 2004, 56:101-112.
20. Hickie I., Naismith S., Ward P.B., et al. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry 2005, 186:197-202.
21. Aihara M., Ida I., Yuuki N., et al. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 2007, 155:245-256.
22. Korczyn A.D., Halperin I. Depression and dementia. J Neurol Sci 2009, 283:139-142.
23. Kunugi H., Ida I., Owashi T., et al. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology 2006, 31:212-220.
24. Van Londen L., Goekoop J.G., Zwinderman A.H., et al. Neuropsychological performance and plasma cortisol, arginine vasopressin and oxycontin in patients with major depression. Psychol Med 1998, 28:275-284.
25. Karege F., Vaudan G., Schwald M., et al. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005, 136:29-37.
26. Xu H., Chen Z., He J., et al. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 2006, 16:551-559.
27. Laske C., Stransky E., Fritsche A., et al. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia. Eur Arch Psychiatry Clin Neurosci 2009, 259:80-85.
28. Weiner M.F., Vobach S., Olsson K., et al. Cortisol secretion and Alzheimer's disease. Biol Psychiatry 1997, 42:1030-1038.
29. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002, 8:448-460.
30. Tsolaki M., Papaliagkas V., Kounti F., et al. Severely stressful events and dementia: a study of an elderly Greek demented population. Psychiatry Res 2010, 176:51-54.
31. Villarreal G., Hamilton D.A., Petropoulos H., et al. Reduced hippocampal volume and total white matter volume in posttraumatic stress disorder. Biol Psychiatry 2002, 52:119-125.
32. Bremner J.D., Randall P., Scott T.M., et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995, 152:973-981.
33. Qureshi S.U., Kimbrell T., Pyne J.M., et al. Greater prevalence and incidence of dementia in older veterans with posttraumatic stress disorder. J Am Geriatr Soc 2010, 58:1627-1633.
34. Martland H.S. Punch drunk. JAMA 1928, 91:1103-1107.
35. McKee A.C., Cantu R.C., Nowinski C.J., et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009, 68:709-735.
36. Jordan B.D. Brain injury in boxing. Clin Sports Med 2009, 28:561-578.
37. Mendez M.F. The neuropsychiatric aspects of boxing. Int J Psychiatry 1995, 25:249-262.
38. Mann D.M., Brown A.M., Prinja D., et al. A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathol Appl Neurobiol 1990, 16:17-25.
39. Welsh-Bohmer K.A. Defining " prodromal" Alzheimer's disease, frontotemporal dementia, and Lewy body dementia: are we there yet?. Neuropsychol Rev 2008, 18:70-72.
40. Folstein M.F., Folstein S.E. McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
41. Nasreddine Z.S., Phillips N.A., Bedirian V., et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699.
42. Tariq S.H., Tumosa N., Chibnall J.T., et al. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder-a pilot study. Am J Geriatr Psychiatry 2006, 14:900-910.
43. Crum R.M., Anthony J.C., Bassett S.S., et al. Population-based norms for the mini-mental state examination by age and education level. JAMA 1993, 269:2386-2391.
44. Ostrosky-Solis F., Lopez-Arango G., Ardila A. Sensitivity and specificity of the mini-mental state examination in a Spanish-speaking population. Appl Neuropsychol 2000, 7:25-31.
45. Roselli M., Tappen R., Williams C., et al. The relation of education and gender on the attention items of the mini-mental state examination in Spanish-speaking Hispanic elders. Arch Clin Neuropsychol 2006, 21:677-686.
46. Hoops S., Nazem S., Siderowf A.D., et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009, 73:1738-1745.
47. Salmon D.P., Bondi M.W. Neuropsychology of Alzheimer's disease. Alzheimer's disease 1999, 39-56. Lippincott Williams & Wilkins, Philadelphia. R.D. Terry, R. Katzman, K.L. Bick (Eds.).
48. Podell K., Keller J.M. Neuropsychological assessment. The American Psychiatric Publishing Textbook of Geriatric Neuropsychiatry 2011, 155-184. American Psychiatric Publishing, Inc, Arlington. 3rd edition. C.E. Coffey, J.L. Cummings (Eds.).
49. Troster A. Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for " mild cognitive impairment" and biomarkers. Neuropsychol Rev 2008, 18:103-119.
50. Claasen D.O., Josephs K.A., Ahskog J.E., et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010, 75:494-499.
51. Kirshner H.S. Frontotemporal dementia and primary progressive aphasia: an update. Curr Neurol Neurosci Rep 2010, 10:504-511.
52. Wittenberg D., Possin K.L., Rascovskyc K., et al. The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev 2008, 18:91-102.
53. Heilbronner R.L., Bush S.S., Ravdin L.D., et al. Neuropsychological consequences of boxing and recommendations to improve safety: a National Academy of Neuropsychology Education paper. Arch Clin Neuropsychol 2009, 24:11-19.
54. Sachdev P.S., Smith J.S., Angus-Lepan H., et al. Pseudodementia twelve years on. J Neurol Neurosurg Psychiatr 1990, 53:254-259.
55. Porter R.J., Gallagher P., Thompson J.M., et al. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 2003, 182:214-220.
56. Airaksinen E., Larsson M., Forsell Y. Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res 2005, 39:207-214.
57. Goldberg E. The new executive brain: frontal lobes in a complex world 2009, Oxford University Press, New York.